NNVC - Rasio utang marang kapitalisasi buku nanoviricides.com

NanoViricides, Inc. (NNVC) operations are shielded from geopolitical risks due to the humanitarian status of its nanotechnologies. The company is developing partnerships with global organizations to combat influenza and herpes. The operating model relies on outsourcing clinical trials to third-party CROs. The debt-to-equity ratio reflects borrowing dynamics, where the 0.00 mark serves as the current indicator.

This ratio is calculated as the ratio of total liabilities to equity, determining the business's degree of financial leverage. An increase in this metric signals a rising debt load and an increase in the weighted average cost of capital (WACC). For NanoViricides, Inc. (NNVC), this is critical due to the costs associated with diversifying third-party manufacturing capacities. By analyzing the debt-to-book capitalization of the company on GURU.Markets, an investor can observe the dynamics of its resilience to external shocks. A decrease in this indicator confirms the strengthening of the financial safety cushion.